Clinical Drug Insights
Bone Fracture Healing: Drugs & Supplements Used in India
Bone fracture healing agents used in India: calcium, vitamin D, teriparatide and anti-osteoporotic drugs, sourced from systematic reviews and ICMR data.
· 5 min read
The Medyzen blog
Everything about running a profitable hospital pharmacy.
Practical, India-specific guides on setup, licensing, costs, operations, and revenue — written for hospital owners and administrators.
Clinical Drug Insights
Bone Fracture Healing Drugs: Hospital Stocking Reliability
Why reliable hospital pharmacy stocking of vitamin D, calcium and perioperative drugs used in bone fracture healing affects nonunion risk and continuity of care.
· 5 min readClinical Drug Insights
Fractured Bone India: Healing Stages and Risk Factors
How a fractured bone in India actually heals — the four biological stages, real delayed-union risk factors, NSAID evidence, and PMJAY/CGHS cost data.
· 5 min readClinical Drug Insights
Bone Fracture Healing Drug Interactions Explained
NSAIDs, corticosteroids, PPIs and smoking each interact with bone fracture healing through documented mechanisms. Here's what peer-reviewed evidence shows.
· 12 min readClinical Drug Insights
Bone Fracture Healing Cost in India: What Drives It
What actually drives bone fracture healing cost in India: implant pricing, PM-JAY package rates, adjunct therapy, and where the real cost variation sits.
· 6 min readClinical Drug Insights
Biosimilar Names: Naming Rules & Brands Stocked in India
How biosimilar names are actually assigned under WHO's INN and biological qualifier framework, why traceability matters, and which India brands hospitals stock.
· 6 min readClinical Drug Insights
Biosimilar Availability at Hospital Pharmacies in India
Why hospital pharmacies in India struggle with biosimilar availability, covering cold chain, CDSCO approval, interchangeability rules and cost gaps.
· 9 min readClinical Drug Insights
Biosimilars in India: Regulatory Pathway & Clinical Guide
How biosimilars are approved and regulated in India, how they differ from generics, and what a hospital pharmacy needs to know before stocking one.
· 7 min readClinical Drug Insights
Biosimilar Drug Interactions & Immunogenicity Risk
What biosimilar drug interactions actually mean clinically — immunogenicity, switching risk and co-medication concerns — sourced from regulatory reviews.
· 6 min readClinical Drug Insights
Biosimilar Cost in India: Price Gap vs Originator Biologics
How much biosimilars actually cost against originator biologics in India, with real trastuzumab, rituximab and insulin pricing examples and sources.
· 6 min readClinical Drug Insights
Asthma Inhaler Names & Classes Stocked in India
Asthma inhaler classes and Indian brand names by category — SABA, ICS, ICS/LABA and reliever combinations — mapped to GINA 2024 treatment steps.
· 6 min readClinical Drug Insights
Asthma Inhaler Availability in Hospital Pharmacies India
Why asthma inhalers are inconsistently stocked in Indian hospital and public-sector pharmacies, and what that gap costs in outcomes.
· 5 min readClinical Drug Insights
Asthma Inhalers in India: Classes, Evidence & Stocking
A clinical-reference overview of asthma inhaler classes used in India, GINA 2024 treatment tracks, NLEM listing and hospital pharmacy stocking reality.
· 6 min readClinical Drug Insights
Asthma Inhaler Drug Interactions Prescribers Should Know
Clinically significant asthma inhaler drug interactions: beta-blockers, theophylline metabolism, and CYP3A4 inhibitors raising inhaled steroid exposure.
· 5 min readClinical Drug Insights
Asthma Inhaler Cost in India: What Sets the Price
What asthma inhalers actually cost in India, why NPPA caps some formulations and not others, and how generic and Jan Aushadhi options change the bill.
· 6 min readClinical Drug Insights
Arthritis Biologic Drugs in India: A Prescriber's Guide
TNF-inhibitor biologics for arthritis in India: etanercept, adalimumab, infliximab biosimilars, NPPA price status, and cold-chain stocking risk.
· 9 min readClinical Drug Insights
Anxiety Medicine Names: Drug Classes Used in India
Anxiety medicine names by drug class used in India: SSRIs, SNRIs, benzodiazepines and buspirone, their evidence base and Schedule H1 status.
· 5 min readClinical Drug Insights
Anxiety Medicine Hospital Stocking: Why Reliability Matters
Why hospital in-house pharmacy stocking reliability for SSRIs and Schedule H1 benzodiazepines matters clinically for anxiety patients, not just operationally.
· 6 min readClinical Drug Insights
Anxiety Medicine India: Drug Classes, Rules and Real Risk
A clinical overview of anxiety medicine used in India — SSRIs versus Schedule H1 benzodiazepines, real prescribing data, dependence risk, and NMHS prevalence.
· 5 min readClinical Drug Insights
Anxiety Medicine Drug Interactions Doctors Must Check
Anxiety medicine drug interactions in benzodiazepines, SSRIs and buspirone, sourced to FDA labeling, CDSCO rules and peer-reviewed pharmacokinetic studies.
· 10 min readClinical Drug Insights
Anxiety Medicine Cost in India: Price Control and Generics
Real anxiety medicine cost data in India: NPPA ceiling prices, DPCO compliance rates, and Jan Aushadhi generic pricing, sourced from government data.
· 5 min readClinical Drug Insights
Anxiety Medicine Availability Across India's System
Anxiety medicine availability in India across public and private channels: DMHP essential drug lists, Schedule H1 access controls, and rural-urban gaps.
· 5 min readClinical Drug Insights
Antidepressant Names in India: SSRIs, SNRIs, TCAs
A doctor-referenced guide to antidepressant names prescribed in India: SSRIs, SNRIs, TCAs and atypicals, with NLEM and NPPA price-control status from primary sources.
· 7 min readClinical Drug Insights
Antidepressants in India: A Clinical Reference Guide
Antidepressant drug classes used in India, their place on the National List of Essential Medicines, and the real scale of the treatment gap.
· 5 min read